Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

NCT02844842 is registered in ClinicalTrials.gov with Roxall Medicina España S.A as lead sponsor.

NCT NCT02844842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02844842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice
Lead sponsor
Roxall Medicina España S.A
Phase
Observational
Overall status
Completed
Start date
November 23, 2016
Completion date
September 6, 2018
Enrollment
152 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis, asthma, rhinoconjunctivitis